Kaempferol Global Market Report 2024

The kaempferol market size has grown strongly in recent years. It will grow from $3.92 billion in 2023 to $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The growth observed in the historic period can be attributed to several contributing factors, including intensive research in plant-based nutrition, advancements in biomedical and pharmacological studies, a heightened focus on antioxidants, progress in biotechnological innovations, and comprehensive studies related to botanicals and phytochemicals. These combined efforts significantly contributed to the understanding and development of applications involving kaempferol and its potential benefits during this historical period.

The kaempferol market size is expected to see steady growth in the next few years. It will grow to $4.96 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%. Anticipated growth in the forecast period is expected to stem from evolving health and wellness trends, a heightened emphasis on the antimicrobial properties of kaempferol, advancements in genetic modification techniques to enhance production, a notable shift in healthcare towards preventive measures, and a rising focus on personalized medicine applications. Key trends anticipated in this forecasted period include the exploration of kaempferol for cardiovascular health benefits, its incorporation into sports nutrition products, the biofortification of crops to increase kaempferol content, expanded research into its neuroprotective effects, and the development of kaempferol-fortified functional beverages. These trends are projected to shape the market, leveraging kaempferol's potential in various health-related domains and consumer-centric applications in the coming period.

The kaempferol market is anticipated to experience growth, propelled by the increasing prevalence of cancer. Cancer, a group of diseases characterized by the uncontrolled growth of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body, has led to a rising demand for kaempferol. Kaempferol, a phytoestrogen found in plants, exhibits anti-cancer properties by inducing apoptosis, arresting the cell cycle, and inhibiting processes such as blood vessel development, migration, and invasion of cancer cells. As reported in April 2022 by the American Cancer Society, there were 1.92 million new cancer cases in the U.S., showing an increase from 1.89 million cases in 2021. Consequently, the growing prevalence of cancer is a significant factor driving the growth of the kaempferol market.

The expansion of the food and beverage industry is anticipated to fuel the growth of the kaempferol market. The food and beverage industry, encompassing the production, processing, distribution, and sale of food and drink products, plays a pivotal role in the utilization of kaempferol. This natural bioactive compound is sought after for its antioxidant properties, prompting its incorporation into various products within the industry. Kaempferol is commonly used in functional foods, beverages, and dietary supplements to enhance nutritional profiles and meet consumer preferences for health-promoting ingredients. In 2023, the Food & Drink Federation reported a 31% increase in food and drink exports in 2022 compared to the previous year. Furthermore, the industry contributed significantly to the economy, with a turnover of $3.52 billion (£10.3 billion) in 2022, accounting for 33% of total Scottish manufacturing. The expanding footprint of the food and beverage industry is a major driver for the kaempferol market, as its applications continue to diversify within the sector.

The kaempferol market is poised for growth, driven by the expanding cosmetics industry. The cosmetics industry, involved in the production, distribution, and sale of personal care and beautification products, is increasingly incorporating kaempferol for its antioxidant properties and potential benefits for skin health. Recognized for its anti-inflammatory and anti-aging characteristics, kaempferol is a sought-after ingredient in skincare products, contributing to skin wellness and providing protection against environmental stressors. Notably, the International Trade Administration reported a 10% growth in cosmetics and beauty product sales in China, reaching $88 billion in 2021. In Canada, the cosmetics industry earned approximately $1.24 billion in 2021, with projected annual revenue growth of 1.45% to reach $1.8 billion by 2024. The robust expansion of the cosmetics industry is a key driver propelling the growth of the kaempferol market.

Product innovations are emerging as a prominent trend in the kaempferol industry, with major companies actively developing innovative products to maintain their market positions. Conagen, a leading biotechnology company based in the United States, exemplifies this trend with its January 2022 announcement. The company successfully developed antioxidant kaempferol through state-of-the-art, proprietary precision fermentation. Precision fermentation is highlighted for its effectiveness and environmental friendliness compared to alternative methods such as chemical synthesis or botanical sourcing for flavonoids such as kaempferol. Conagen's innovative approach enables brands in the nutrition, cosmetics, and personal care sectors to adopt a more natural stance by incorporating their kaempferol in formulations. This emphasis on innovation underscores the dynamic landscape of the kaempferol market, with companies actively pursuing advancements to meet evolving industry demands.

In October 2021, Abcam, a prominent biotechnology company headquartered in the UK, completed the acquisition of BioVision Inc. for a total sum of $340 million. This strategic acquisition involved the integration of BioVision into Abcam, facilitating internal innovation and significantly scaling up Abcam's biochemical and cellular assay businesses. BioVision Inc., a company based in the United States, specializes in the manufacturing and marketing of an extensive array of products, including assay kits, antibodies, recombinant proteins, and various kaempferol-related products. This acquisition stands to bolster Abcam's portfolio and strengthen its market presence within the biotechnology sector.

Major companies operating in the kaempferol market report are Fujifilm Wako Pure Chemical Corporation, Merk Millipore, LGC Group, Abcam plc, ChromaDex Corporation, Cayman Chemical Company, BioVision Inc., Clearsynth Labs Ltd., Enzo Life Sciences Inc., Santa Cruz Biotechnology Inc., AppliChem GmbH, Conagen Inc., MedChemExpress LLC, BioBioPha Co. Ltd., FoodChem International Corporation, Oakwood Products Inc., Spectrum Chemical Mfg. Corp., Aktin Chemicals Inc., BOC Sciences, AK Scientific Inc., Chemfaces Biochemical Co. Ltd, INDOFINE Chemical Company Inc., Risun Bio-Tech Inc., Shaanxi NHK Technology, TCI Chemicals (India) Pvt. Ltd.

North America was the largest region in the kaempferol market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kaempferol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the kaempferol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The kaempferol market is segmented based on its sources, including tea, fruits, vegetables, and medicinal plants. Within this segmentation, vegetables encompass a variety of edible plant parts - fruits, seeds, roots, tubers, bulbs, stems, leaves, or flowers - used for kaempferol extraction. This compound shows potential as a chemopreventive agent against cancer. Purity levels for kaempferol range from 10%, 20%, 50%, 95%, to 98%. Its applications span across diverse industries such as food and beverages, cosmetics, pharmaceuticals, dietary supplements, and more.

The kaempferol market research report is one of a series of new reports that provides kaempferol market statistics, including kaempferol industry global market size, regional shares, competitors with a kaempferol market share, detailed kaempferol market segments, market trends, and opportunities, and any further data you may need to thrive in the kaempferol industry. This kaempferol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The kaempferol market consists of sales of luteolin, apigenin, flavanol, polyphenol, and glycoside. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.